Semmax Financial Advisors Inc. Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Semmax Financial Advisors Inc. reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,787 shares of the healthcare conglomerate’s stock after selling 284 shares during the quarter. Semmax Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $1,713,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Tealwood Asset Management Inc. bought a new stake in UnitedHealth Group during the third quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV boosted its stake in UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after buying an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after acquiring an additional 3,006 shares during the last quarter. Americana Partners LLC boosted its stake in shares of UnitedHealth Group by 10.8% in the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares in the last quarter. Finally, Captrust Financial Advisors raised its position in UnitedHealth Group by 0.9% in the 3rd quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate’s stock worth $123,054,000 after purchasing an additional 1,789 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on UNH. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Barclays raised their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday. TD Cowen increased their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Stephens lowered their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, UBS Group reduced their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $618.26.

UnitedHealth Group Trading Up 0.3 %

NYSE:UNH opened at $610.20 on Friday. The company’s 50-day simple moving average is $585.43 and its 200 day simple moving average is $556.38. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $561.55 billion, a P/E ratio of 39.75, a PEG ratio of 1.79 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the company earned $6.56 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.